Therefore, we examined breast cancer cell lines with PIK3CA mutations in this study to investigate whether inhibition of PDK1 activity had antitumor effects in breast cancer cells subjected to growth factor stimulation. The gene discussed is PIK3CA; the disease is breast cancer.